Solanbridge Group, Inc.
OTC: SLNX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David J. Cutler
- Headquarters
- The Woodlands, United States
- IPO year
- 2007
- Market cap
- $476.0K
- Website
- https://www.solanbridgegroup.com
Loading SLNX…
Loading profile data…Frequently asked questions about SLNX
What does Solanbridge Group, Inc. (SLNX) do?
Solanbridge Group, Inc. concentrates its efforts on cultivating and marketing medical cannabis in Nova Scotia, Canada. Additionally, the organization is committed to developing and distributing a range of CBD-enriched products throughout Nevada, California, and Colorado. The enterprise was founded in 2000 and maintains its main corporate offices...
Where does SLNX trade?
Solanbridge Group, Inc. (SLNX) trades on the Other OTC.
What sector is SLNX in?
Solanbridge Group, Inc. (SLNX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Solanbridge Group, Inc.?
David J. Cutler is the chief executive officer of Solanbridge Group, Inc. (SLNX).
Where is Solanbridge Group, Inc. headquartered?
Solanbridge Group, Inc. is headquartered in United States.
Does SLNX pay a dividend?
Solanbridge Group, Inc. (SLNX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SLNX go public?
Solanbridge Group, Inc. (SLNX) completed its initial public offering in 2007.